Top Articles

What’s Ahead for Labs? It’ll Be Quite Different

Is a ‘perfect storm’ of unwelcome factors gathering that will confront all laboratories in serious ways?

CEO SUMMARY: In many ways, the nation’s clinical laboratories performed magnificently in response to the SARS-CoV-2 outbreak last winter. But that magnificent performance has taken its toll on the infrastructure and personnel within these labs. The Dark Report...

Read More

Academic, Commercial Collaboration for Testing

COVID-19 assay developed by SUNY Upstate now used at 64 campuses statewide to keep them open

CEO SUMMARY: In several important ways, this collaboration involving an academic clinical laboratory and a commercial company has paid big dividends, not just for the two partners, but also the parent university that oversaw the project. The two partners developed a SARS-CoV-2 test, t...

Read More

Lab Market Update Critics Say New At-Home Test Is Expensive and Late to Market

They say the first over-the-counter test for COVID-19 to get EUA status from the FDA “is a waste of money”

ONCE AGAIN, THE COMBINATION of the pandemic and the federal government may be creating a credible new competitor in the in vitro diagnostics (IVD) industry. This time, the lucky company is Ellume, which was just awarded $231.8 million from the Biden administration to s...

Read More

Variant Sequencing of SARS-CoV-2 Creates Opportunities for Labs

Increasing need for local labs to identify, report variants

CEO SUMMARY: Variants of the COVID-19 virus are appearing across the world. Recent data show the same variants will infect people in several different countries. Here in the United States, interest is growing in having clinical laboratories sequence specimens from patients who test pos...

Read More

IVD Update Proscia Lands Major Deals as Digital Pathology Demand Grows

Just weeks apart, Proscia lands big contracts with the Joint Pathology Center and LabPON

EVEN AS THE WORLDWIDE COVID-19 PANDEMIC DERAILED SOME INDUSTRIES, it gave a major boost to digital pathology. That has meant an expanding market for Proscia, a seven-year-old provider of digital and computational pathology solutions. Established in 2014, Proscia recently won ...

Read More

IVD, Diagnostics & Informatics Update hc1, Visiun, and Viewics: Analytics Market Evolves

In last 36 months, three billion-dollar firms purchased or partnered with analytics companies

CEO SUMMARY: To understand any development in the marketplace, it is best to follow the money. That Roche, Quest Diagnostics, and LabCorp spent money either to purchase or partner with a lab analytics company in the past 36 months indicates that these enterprises believe acquiring or ...

Read More

Clinical Labs Have the Opportunity to Deliver Value

FOR DECADES, PATHOLOGISTS AND CLINICAL LABORATORY PROFESSIONALS have called attention to the single most powerful resource possessed by their lab organizations: patient lab test data. Everyone in lab medicine is familiar with the oft-repeated statement that the cost of lab testing is about 3¢ to 5¢ on the healthcare dollar, but lab test data is involved in 60% to 70...

Read More

Don’t Be at the Mercy of the Tumultuous Healthcare Revolution

Subscribe to The Dark Report for as little as $15.27 per week.


Get the most expert business intelligence for clinical laboratories and pathology groups available today. Subscribe to The Dark Report.

How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.